Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Virus vs. virus: adenovirus vectored vaccine to defeat respiratory syncytial virus.

Literature DB >> 28149851

Virus vs. virus: adenovirus vectored vaccine to defeat respiratory syncytial virus.

Alessandra Vitelli¹, Alfredo Nicosia².

Abstract

Entities: Species

Year: 2016 PMID： 28149851 PMCID： PMC5233505 DOI： 10.21037/atm.2016.12.08

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

26 in total

1. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

Authors: A Z Kapikian; R H Mitchell; R M Chanock; R A Shvedoff; C E Stewart
Journal: Am J Epidemiol Date: 1969-04 Impact factor: 4.897

2. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.

Authors:
Journal: Pediatrics Date: 1998-09 Impact factor: 7.124

3. Vaccines against respiratory syncytial virus: The time has finally come.

Authors: Barney S Graham
Journal: Vaccine Date: 2016-05-13 Impact factor: 3.641

4. Risk of primary infection and reinfection with respiratory syncytial virus.

Authors: W P Glezen; L H Taber; A L Frank; J A Kasel
Journal: Am J Dis Child Date: 1986-06

Review 5. Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.

Authors: Stefania Capone; Anna Morena D'Alise; Virginia Ammendola; Stefano Colloca; Riccardo Cortese; Alfredo Nicosia; Antonella Folgori
Journal: Expert Rev Vaccines Date: 2013-04 Impact factor: 5.217

6. Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation.

Authors: Teresa R Johnson; David Rangel; Barney S Graham; Douglas E Brough; Jason G Gall
Journal: Mol Ther Date: 2013-06-10 Impact factor: 11.454

7. Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.

Authors: Maximillian S Habibi; Agnieszka Jozwik; Spyridon Makris; Jake Dunning; Allan Paras; John P DeVincenzo; Cornelis A M de Haan; Jens Wrammert; Peter J M Openshaw; Christopher Chiu
Journal: Am J Respir Crit Care Med Date: 2015-05-01 Impact factor: 30.528

8. RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.

Authors: Agnieszka Jozwik; Maximillian S Habibi; Allan Paras; Jie Zhu; Aleks Guvenel; Jaideep Dhariwal; Mark Almond; Ernie H C Wong; Annemarie Sykes; Matthew Maybeno; Jerico Del Rosario; Maria-Belen Trujillo-Torralbo; Patrick Mallia; John Sidney; Bjoern Peters; Onn Min Kon; Alessandro Sette; Sebastian L Johnston; Peter J Openshaw; Christopher Chiu
Journal: Nat Commun Date: 2015-12-21 Impact factor: 14.919